| A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients (NCT01014975) | Grifols Therapeutics LLC | 2009-11-01 |
| A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer (NCT01051284) | Georgetown University | 2009-11-01 |
| Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma (NCT00977145) | Craig L Slingluff, Jr | 2009-11-01 |
| Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia (NCT01043458) | Abbott | 2009-11-01 |
| Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion (NCT01011374) | Retina Associates of Cleveland, Inc | 2009-11-01 |
| Muscle Malonyl Coa Biomarker Assay Development (NCT01003444) | Pfizer | 2009-11-01 |
| CMX001 in Post-transplant Patients With BK Virus Viruria (NCT00793598) | Jazz Pharmaceuticals | 2009-11-01 |
| Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults (NCT00914862) | Takeda | 2009-11-01 |
| Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita (NCT01001598) | Boston Children's Hospital | 2009-11-01 |
| A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions (NCT01476215) | GlaxoSmithKline | 2009-11-01 |
| Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas (NCT01259518) | Trin Therapeutics GmbH | 2009-11-01 |
| Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer (NCT00903006) | M.D. Anderson Cancer Center | 2009-11-01 |
| A Study of MORAb-009 in Patients With Solid Tumor (NCT01018784) | Eisai Co., Ltd. | 2009-11-01 |
| Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C (NCT01018615) | University of North Carolina, Chapel Hill | 2009-11-01 |
| Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease (NCT01099332) | Adeona Pharmaceuticals | 2009-11-01 |
| Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS) (NCT00950248) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet (NCT01004614) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-11-01 |
| Topical Bethanechol for Improvement of Esophageal Dysmotility (NCT01031043) | Augusta University | 2009-11-01 |
| Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects (NCT01037543) | Hanmi Pharmaceutical Company Limited | 2009-11-01 |
| The McKenzie System With Arthritic Knees: Do Some Knees Respond to Specific Exercise More Than General or no Exercise (NCT01641874) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2009-11-01 |
| Study of a Novel Therapeutic Vaccine for Hepatitis C Virus (NCT01094873) | ReiThera Srl | 2009-11-01 |
| AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma (NCT01029418) | National Cancer Centre, Singapore | 2009-11-01 |
| Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents (NCT01177969) | University of South Florida | 2009-11-01 |
| To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors (NCT01028755) | Bayer | 2009-11-01 |
| SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS) (NCT01083667) | Weill Medical College of Cornell University | 2009-11-01 |
| AZD9668 Relative Bioavailability (NCT01034982) | AstraZeneca | 2009-11-01 |
| Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma (NCT01019174) | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | 2009-11-01 |
| Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS) (NCT01062152) | Telik | 2009-11-01 |
| Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors (NCT01014429) | Nerviano Medical Sciences | 2009-11-01 |
| Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT01160731) | Cancer Trials Ireland | 2009-11-01 |
| Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation (NCT01014247) | Bayer | 2009-11-01 |
| This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects (NCT01030224) | AstraZeneca | 2009-11-01 |
| A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER) (NCT02126917) | Zogenix, Inc. | 2009-11-01 |
| Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer (NCT00987766) | Vanderbilt-Ingram Cancer Center | 2009-11-01 |
| Effect of BIA 9-1067 on Rasagiline Pharmacokinetics (NCT01532128) | Bial - Portela C S.A. | 2009-11-01 |
| Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations (NCT01014052) | QLT Inc. | 2009-11-01 |
| Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG (NCT01730417) | Bennett Chin | 2009-11-01 |
| A Drug Interaction Study of JNJ-31001074 and Ketoconazole in Healthy Volunteers (NCT00915746) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-11-01 |
| Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency (NCT00968591) | Novartis Pharmaceuticals | 2009-11-01 |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions (NCT02962323) | Torrent Pharmaceuticals Limited | 2009-11-01 |
| Aqueous Mushroom Extract and Intraocular Pressure (NCT01017068) | University of Benin | 2009-11-01 |
| Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults (NCT01499706) | Ohio University College of Osteopathic Medicine | 2009-11-01 |
| Behavior Therapy Prior to Bariatric Surgery (NCT01125397) | Mayo Clinic | 2009-11-01 |
| Early Detection of Lung Tumors by Sniffer Dogs - Evaluation of Sensitivity and Specificity (NCT01141842) | Schillerhoehe Hospital | 2009-11-01 |
| Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT02353572) | University of Colorado, Denver | 2009-11-01 |
| Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer (NCT01523808) | ERYtech Pharma | 2009-11-01 |
| The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3) (NCT00990808) | Merck Sharp & Dohme LLC | 2009-11-01 |
| Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes (NCT01238224) | Vastra Gotaland Region | 2009-11-01 |
| Human Factors Analysis in VR for Burn Treatment (NCT00409552) | National Institute on Drug Abuse (NIDA) | 2009-11-01 |
| The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics (NCT00986531) | AstraZeneca | 2009-11-01 |
| Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (NCT01028209) | Institute for Neurodegenerative Disorders | 2009-11-01 |
| A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations (NCT01476189) | GlaxoSmithKline | 2009-11-01 |
| A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers (NCT00992342) | Pfizer | 2009-11-01 |
| Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma (NCT00979173) | Annick Desjardins | 2009-11-01 |
| Collagenase Total Occlusion-1 Trial (NCT01271335) | Sunnybrook Health Sciences Centre | 2009-11-01 |
| Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene Therapy (NCT00991224) | University of Pennsylvania | 2009-11-01 |
| Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers (NCT01015703) | BTG International Inc. | 2009-11-01 |
| Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer (NCT01038778) | National Cancer Institute (NCI) | 2009-10-29 |
| Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease (NCT00985517) | Sangamo Therapeutics | 2009-10-29 |
| Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00989651) | National Cancer Institute (NCI) | 2009-10-28 |
| A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy Volunteers (NCT00999128) | Genentech, Inc. | 2009-10-26 |
| A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease (NCT00988598) | Pfizer | 2009-10-26 |
| Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours (NCT00979134) | AstraZeneca | 2009-10-21 |
| Paxil CR Bioequivalence Study Brazil - Fed Administration (NCT01339247) | GlaxoSmithKline | 2009-10-20 |
| A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes (NCT00976261) | GlaxoSmithKline | 2009-10-17 |
| A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036) (NCT00989079) | Merck Sharp & Dohme LLC | 2009-10-16 |
| BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC) (NCT00979576) | Boehringer Ingelheim | 2009-10-16 |
| An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836. (NCT00996268) | GlaxoSmithKline | 2009-10-15 |
| First Time in Human Study With GSK1325756 (NCT01209052) | GlaxoSmithKline | 2009-10-15 |
| Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma (NCT00932698) | Millennium Pharmaceuticals, Inc. | 2009-10-12 |
| A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris (NCT01019603) | Stiefel, a GSK Company | 2009-10-12 |
| Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days (NCT00989404) | GlaxoSmithKline | 2009-10-12 |
| Hematopoietic Stem Cell Transplant in Devic's Disease (NCT00787722) | Northwestern University | 2009-10-10 |
| VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years (NCT00995982) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-10-08 |
| A Study of GSK573719 in Healthy Japanese Male Subjects (NCT01013974) | GlaxoSmithKline | 2009-10-05 |
| Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma (NCT00963820) | Millennium Pharmaceuticals, Inc. | 2009-10-01 |
| Evaluation of the Efficiency of the Echelon Foot in Traumatic Trans Tibial Amputees (NCT01004926) | Sheba Medical Center | 2009-10-01 |
| Naltrexone and Hypoglycemia in Type 1 Diabetes (NCT01053078) | University of Minnesota | 2009-10-01 |
| Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial (NCT01010243) | University of Regensburg | 2009-10-01 |
| Ascending Dose Study of the Safety and Tolerability of REGN668(SAR231893) in Normal Healthy Volunteers (NCT01015027) | Regeneron Pharmaceuticals | 2009-10-01 |
| Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027) (NCT01106287) | Merck Sharp & Dohme LLC | 2009-10-01 |
| Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes (NCT01107899) | Eli Lilly and Company | 2009-10-01 |
| CG400549 Single Ascending Dose Study (NCT01085578) | CrystalGenomics, Inc. | 2009-10-01 |
| Relative Bioavailability of Colcrys™ 0.6 mg Tablets in Healthy Young and Elderly Volunteers Under Fasted Conditions (NCT01001052) | Mutual Pharmaceutical Company, Inc. | 2009-10-01 |
| A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer (NCT00878449) | AbbVie (prior sponsor, Abbott) | 2009-10-01 |
| Bioequivalence Study Of Gabapentin Between Tablet And Liquid Formulation And The Food Effect Study Of Liquid Formulation (NCT00987779) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-10-01 |
| Wound Healing of Incisional Wounds for Bilateral Hernia Repair (NCT01008111) | Wake Forest University | 2009-10-01 |
| Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers (NCT00991016) | Pfizer | 2009-10-01 |
| Rehabilitation of Women Following Treatment for Gynaecological Cancer; a Randomized, Controlled Study (NCT01304745) | Haukeland University Hospital | 2009-10-01 |
| Adjuvant Valproate for High Grade Sarcomas (NCT01010958) | Columbia University | 2009-10-01 |
| Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer (NCT01026623) | National Cancer Institute (NCI) | 2009-10-01 |
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors (NCT01081808) | Roger Williams Medical Center | 2009-10-01 |
| The Effect of Combined Decongestive Therapy and Pneumatic Compression Pump on Body Image in Patients With Lymphedema (NCT02650297) | badri jaafari | 2009-10-01 |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status (NCT00986297) | University of Texas Southwestern Medical Center | 2009-10-01 |
| A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa (NCT00931346) | International AIDS Vaccine Initiative | 2009-10-01 |
| Safety and Efficacy Study of Intravenous Uricase-PEG 20 (NCT01021241) | EnzymeRx | 2009-10-01 |
| CABG Combined Pedicled Omentum Wrapped Autologous Atrial Tissue Patch Cardiomyoplasty for Ischemic Cardiomyopathy (NCT00972114) | China National Center for Cardiovascular Diseases | 2009-10-01 |
| Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions (NCT01276080) | Ranbaxy Laboratories Limited | 2009-10-01 |
| Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients (NCT00932256) | Magna Pharmaceuticals, Inc. | 2009-10-01 |
| Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02 (NCT01093664) | Affiris AG | 2009-10-01 |